PML report

Published: 10 March 2022| Version 2 | DOI: 10.17632/33ghjt876c.2
Contributor:
Noriyasu Fukushima

Description

This data involves a case of PML after HSCT and blinatumomab.

Files

Institutions

Hiroshima University Research Institute for Radiation Biology and Medicine Research Center for Radiation Genome Medicine

Categories

Case Report

Licence